ImmuPharma PLC (“ImmuPharma” or the “Company”) Holding(s) in Company

28th November 2017 - 5:21 pm

ImmuPharma PLC (LSE:IMM), the specialist drug discovery and development company, has received notification that Alto Invest now holds 5,242,536 ordinary shares of 10p each in the Company, representing 3.96% of the Company’s issued share capital with voting rights.

This announcement contains inside information for the purposes of Article 7 of Regulation (EU) 596/2014.

Share this article